AstraZeneca has said a “small number” of its employees are under investigation in China.
The confirmation came after Bloomberg reported on Thursday that police were investigating five current and former AstraZeneca employees over infringement of data privacy laws and importing an unlicensed medicine.
The drugmaker did not provide any further information.
您已閱讀46%（354字），剩余54%（424字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。